Align Technology, Inc. (ALGN)

NASDAQ · Health Care · market cap 12.53B

Share price

$149.71

At the last nightly close

Intrinsic value

$140.27

Range $140.27 – $171.09 — the conservative figure is the low end.

Margin of safety

-6.3%

($140.27 − $149.71) ÷ $149.71

EV / EBIT

25.5

On the median operating profit of 15 fiscal years through 2025.

How these numbers are computed

The valuations are calculated in Python from filed accounts, not written by a language model. Three methods run side by side: earnings power value, which capitalises a normalised operating profit; a free-cash-flow model; and the Graham Number as an asset-side cross-check. The conservative figure above is the low end of what they agree on.

The frame gives no credit for growth. A company that compounds will therefore read as expensive against it — that is deliberate. It is a price-discipline floor, not a price target, and it is not a view on what the shares will do.

The EV/EBIT ranking uses the median operating profit of up to fifteen fiscal years — a full cycle — where the free screeners use the last twelve months. When the data cannot support a method, the figure reads n/a rather than a number: a free-cash-flow valuation on a bank, a PEG on erratic earnings, a multiple on a company with no operating profit to speak of.

Fundamentals from SEC EDGAR. Prices, market data and technicals from yfinance. Valuation computed 2026-09-03.

Key metrics

Price / earnings26.0
Price / book2.5
EV / EBITDA10.5
FCF / EV+2.8%
Return on equity+10.2%
Return on assets+7.6%
Debt / equity0.03
Gross margin+70.7%

Market position

52-week high$197.51
52-week low$124.88
From 52-week high-24.2%
RSI (14)37.5
200-day moving average$164.92

Annual financials

PeriodRevenueOperating incomeNet incomeEPSFree cash flow
2025-FY4.03B585.3M410.4M5.66490.8M
2024-FY4.00B671.8M421.4M5.63622.7M
2023-FY3.86B656.7M445.1M5.82608.1M
2022-FY3.73B654.0M361.6M4.62276.8M
2021-FY3.95B976.4M772.0M9.69771.4M

Filed figures from SEC EDGAR, in the reporting currency.

Next earnings

Q4 2026 expectedOctober 28, 2026
Consensus EPS estimate2.79

Recent news

The figures above are the arithmetic. To see what a board of eight AI agents makes of them — macro, sector, filings, news and a devil's advocate whose only job is to attack the thesis — run the full analysis on ALGN.

Run the board on ALGN

10 free analyses · no signup, no card

This page presents computed figures and filed financial data for information only. It is not investment advice, not a recommendation to buy or sell any security, and not a statement about what these shares will do. Sperio is a research tool, not an investment adviser. Figures are derived automatically from public filings and market data and may be incomplete, out of date or wrong. See the Terms & Disclaimer.